Drug intelligence / Profile preview

p-Synephrine

Development stage
Phase 3
Modality
Small Molecules
Administration
Oral
01

Overview

p-Synephrine is a naturally occurring alkaloid found primarily in the bitter orange (Citrus aurantium) plant. It is widely used as an ingredient in dietary supplements marketed for weight loss and sports performance due to its potential to increase fat oxidation and energy expenditure. The compound exists mainly as the l- or R-(−)-enantiomer in nature, while synthetic forms may be racemic mixtures with reduced pharmacological activity compared to the natural form[1][2]. Mechanistically, p-synephrine acts as an agonist at several receptors: - It is a selective agonist of Neuromedin U2 receptor (NMU2R), which plays roles in regulating food intake, energy balance, stress response, and nociception. - It also activates β-3 adrenergic receptors—contributing to lipolytic effects—and has some activity at α1-adrenoreceptors and serotonergic (5-HT1D/5-HT2A) receptors[1][5]. Additionally, it exhibits anti-inflammatory properties by inhibiting eotaxin-1 expression via STAT6 modulation and shows antioxidant effects in animal models[6]. p-Synephrine is not approved as a pharmaceutical drug for any specific indication but is commonly included in over-the-counter dietary supplements.

Brand names
SimpatholSympatolSynephrin
Other names
synephrinepara-synephrinel-synephrineR-(−)-synephrine
02

Targets

NMUR2 (Neuromedin-U receptor 2)HTR2A (Serotonin receptor 5-HT2A)HTR1D (5-hydroxytryptamine receptor 1D)ADRA1A (α1A)ADRB3 (β3)

Beyond the preview

Go deeper on p-Synephrine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on p-Synephrine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call